Latest Pharmaceutical Insights
IMA Active
Q&A: The latest innovation in tablet press
Olivia Friett, editor of European Pharmaceutical Manufacturer, spoke to Luca Cavazzini, sales & marketing director at IMA Active, about the company’s newest developments.
12 Dec 2025
Astoriom
Why robust temperature control is essential to protect product integrity
Philip Bradley, general manager at Astoriom shares why robust temperature control is essential to protect product integrity, compliance, and patient safety.
12 Dec 2025
Protecting vaccine shipments in 2026: What the next era of Cold Chain looks like
Barbara Morgan, regional president Americas at Envirotainer explores what the next era of cold chain looks like.
10 Dec 2025
Pharmaceutical Insights + Pharmaceutical Logistics & Distribution Insights
SHL Medical
Making at-home lyophilised drug delivery possible
SHL Medical’s Reunite is showing that self-administering lyophilised drugs at home is finally within reach.
9 Dec 2025
Aragen
Q&A: Aragen shares 2026 predictions
European Pharmaceutical Manufacturer spoke to Ashu Tandon, CCO, Aragen at CPHI Frankfurt about their 2026 predictions for the company.
8 Dec 2025
Shutterstock - DIA TV
Q&A: Syngene at CPHI Frankfurt
At CPHI Frankfurt, we sat down with Peter Bains, MD & CEO of Syngene International, to discuss the company’s recent investments in peptides and antibody–drug conjugates (ADCs) and the broader evolution of integrated development in biologics.
5 Dec 2025
Powering digital transformation in drug discovery
Shafique Virani, chief corporate development officer and interim chief medical officer, Recursion, delves into digital transformation within drug discovery and the power of AI-enabled platforms in the future of therapeutics.
7 Dec 2022
The regulatory shift: Laboratory services post-Brexit
Chris Allen, CEO of UK-based analytical testing and scientific consultancy provider Broughton, explains the challenges — and opportunities — that Brexit holds for laboratory services.
12 Oct 2022
Perspective on pharma: Post-pandemic lessons
Noel Maestre, PE, vice president of Life Sciences, and David Estape, technology manager Biotechnology at CRB discuss how virus response rewrote the playbook for vaccine response, but even more change is necessary to deal with emerging threats.
12 May 2022
How pharmaceutical manufacturers can benefit from moving to cloud today
For pharmaceuticals manufacturers, progressing digitalisation and moving to the cloud has been notoriously slow, and misperceptions of what moving to the cloud entails have been a significant factor in this lack of adoption.
12 May 2022
Driving drug discovery with micromotors
Dave Walsha, sales manager at precision drive system supplier, Electrical Mechanical Systems (EMS), explores how micromotors are helping drug discovery.
25 Apr 2022
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Cancer immunotherapy: the best is yet to come
Justin Wilson, partner and attorney at Withers & Rodgers, discusses his opinion on the promising innovations in the microbiome and the role of IP in supporting the discovery of new drugs and treatments.
13 Apr 2022
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00